We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$779M
AUM Growth
-$43.6M
Cap. Flow
-$12.2M
Cap. Flow %
-1.57%
Top 10 Hldgs %
30.36%
Holding
464
New
2
Increased
1
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
VKTX icon
Viking Therapeutics
VKTX
+$316K
2
PFG icon
Principal Financial Group
PFG
+$208K
3
BAX icon
Baxter International
BAX
+$196K

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$1.31M
2
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$1.24M
3
MSFT icon
Microsoft
MSFT
+$1.06M
4
WMT icon
Walmart Inc
WMT
+$675K
5
AMZN icon
Amazon
AMZN
+$586K

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Financials 14.54%
3 Healthcare 12.64%
4 Industrials 12.07%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THR
251
DELISTED
Thermon Group Holdings
THR
$557K 0.07%
20,000
– –
RJF icon
252
Raymond James Financial
RJF
$34.4B
$556K 0.07%
4,000
– –
AZTA icon
253
Azenta
AZTA
$1.42B
$554K 0.07%
16,000
– –
FFBC icon
254
First Financial Bancorp
FFBC
$3.55B
$550K 0.07%
22,000
– –
JNPR
255
DELISTED
Juniper Networks
JNPR
$543K 0.07%
15,000
– –
MO icon
256
Altria Group
MO
$113B
$540K 0.07%
9,000
– –
TKO icon
257
TKO Group
TKO
$13.7B
$535K 0.07%
3,500
– –
KIM icon
258
Kimco Realty
KIM
$16.4B
$531K 0.07%
25,000
– –
ARCO icon
259
Arcos Dorados Holdings
ARCO
$1.76B
$530K 0.07%
65,779
– –
AXON
260
Axon Enterprise
AXON
$42.1B
$526K 0.07%
1,000
– –
LGND icon
261
Ligand Pharmaceuticals
LGND
$6.02B
$526K 0.07%
5,000
– –
SNX icon
262
TD Synnex
SNX
$20.7B
$520K 0.07%
5,000
– –
TBPH icon
263
Theravance Biopharma
TBPH
$877M
$519K 0.07%
58,142
– –
ACM icon
264
Aecom
ACM
$9.63B
$517K 0.07%
5,579
– –
CADE
265
DELISTED
Cadence Bank
CADE
$510K 0.07%
16,800
– –
LUV icon
266
Southwest Airlines
LUV
$23B
$504K 0.06%
15,000
– –
TWI icon
267
Titan International
TWI
$465M
$503K 0.06%
60,000
– –
MDGL icon
268
Madrigal Pharmaceuticals
MDGL
$11.8B
$497K 0.06%
1,500
– –
LMNR icon
269
Limoneira
LMNR
$249M
$496K 0.06%
28,000
– –
OXY icon
270
Occidental Petroleum
OXY
$55.7B
$494K 0.06%
10,000
– –
NTRS icon
271
Northern Trust
NTRS
$33.7B
$493K 0.06%
5,000
– –
DOW icon
272
Dow Inc
DOW
$21.9B
$491K 0.06%
14,071
– –
KN icon
273
Knowles
KN
$3.36B
$486K 0.06%
32,000
– –
PAMT
274
PAMT Corp
PAMT
$315M
$486K 0.06%
40,000
– –
VRTX icon
275
Vertex Pharmaceuticals
VRTX
$123B
$485K 0.06%
1,000
– –
9 10
11
12 13

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q1 2025 Portfolio in Review

As of Q1 2025, NJ State Employees Deferred Compensation Plan held 464 positions worth $779M, down 5.3% from $823M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.7%. NJ State Employees Deferred Compensation Plan opened 2 new positions and exited 20, leaving the 464-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q1 2025 buy was Principal Financial Group: 2,500 shares worth $211K.
  • NJ State Employees Deferred Compensation Plan added most to Viking Therapeutics in Q1 2025, an estimated $316K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q1 2025 reduction was Microsoft, cutting an estimated $1.06M.
  • NJ State Employees Deferred Compensation Plan fully exited Altair Engineering Inc in Q1 2025, selling an estimated $1.31M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 30% of its $779M portfolio in Q1 2025.
  • NJ State Employees Deferred Compensation Plan opened 2 new positions and closed 20 in Q1 2025.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 5.3% quarter-over-quarter to $779M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2025, filed 9 May 2025.